BIRC5 overexpression was reported in breast cancer, lung adenocarcinoma, and neuroblastic malignance specimens (Hagenbuchner et al., 2016; Hamy et al., 2016; Cao et al., 2019). This evidence concerns the gene BIRC5 and breast cancer.